Get started
Author

Giovanni Fumagalli

Observed names: G Fumagalli, G. Fumagalli, Giovanni Fumagalli6
ORCID: 0009-0009-2092-7501
Observed ORCIDs: 0009-0009-2092-7501, 0000-0001-6625-2057
OpenAlex ID: A5010256378
Post-tuberculosis lung disease: a guide for clinicians
2025 · Giovanni Fumagalli, Jessica Mencarini, et al. · Infection · 8
Is personality the key in cognitive‐behavioural therapy for eating disorders? A review
2021 · Giovanni Fumagalli, Davide Margola · Clinical Psychology & Psychotherapy · 7
Treatment outcomes of clofazimine-containing regimens in Mycobacterium avium complex pulmonary disease: a retrospective study from two European reference centers
2026 · Serena Piccirillo, Niccolò Riccardi, et al. · Infection · 4
PDF
Tuberculosis Stewardship: Reducing Diagnostic Delay Across the Clinical Spectrum in Low-Incidence Settings
2026 · Sara Benevento, Niccolò Riccardi, et al. · Microorganisms · 3
PDF
Treating tuberculosis without rifampicin: an open dilemma
2026 · Andrea Calcagno, Amina Zaffagnini, et al. · Respiratory Medicine · 1
Individualized TB care for drug-susceptible pulmonary tuberculosis: clinical alternatives when HRZE is contraindicated or not tolerated
2026 · Lucia Allavena, Jessica Mencarini, et al. · Expert Review of Respiratory Medicine · 1
Impact of the COVID-19 pandemic on tuberculosis services in a rural area of Senegal
2025 · Giulia Menotti, Maddalena Giglia, et al. · Infezioni in Medicina · 1
PDF
TB Anywhere, TB Everywhere. The First Case of pre-Extensively Drug Resistant Tuberculosis Treated with BPaL in Italy: Challenges and Opportunities for Transborder Collaboration
2024 · Giovanni Fumagalli, Niccolò Riccardi, et al. · Microbial Drug Resistance · 1
ERS International Congress 2023: highlights from the Respiratory Infections Assembly
2023 · Francesco Bindo, Giovanni Fumagalli, et al. · ERJ Open Research · 1
PDF
Ischaemic Priapism: A Complication of Self-Administered Hyaluronic Acid Gel as an Injectable Filler for Penile Augmentation
2023 · Marco Tozzi, Michele Talso, et al. · Archivos Españoles de Urología · 1
Treatment Outcomes of Drug-Susceptible Pulmonary Tuberculosis in Older Adults: A 24-Year Retrospective Study
2026 · Irene Sini, Lucia Allavena, et al. · Antibiotics
Active screening for asymptomatic versus symptomatic tuberculosis in high-risk groups in a low-prevalence country: a retrospective study
2026 · Margherita S. Silani, Serena Piccirillo, et al. · Infection
Outpatient Treatment with Isavuconazole for Recurrent Chronic Cavitary Pulmonary Aspergillosis in a Residual Post-Lobectomy Cavity: A Case Report
2026 · Marialuisa Valente, Giovanni Fumagalli, et al. · Infectious Disease Reports
Multidisciplinary care should be the standard in referral centers for non tuberculous mycobacterial disease
2026 · Giovanni Fumagalli, Niccolò Riccardi · Respiratory Medicine
Predictors of treatment initiation in nontuberculous mycobacterial pulmonary disease: a real-life retrospective analysis
2026 · Giovanni Fumagalli, Niccolò Riccardi, et al. · European Journal of Clinical Microbiology & Infectious Diseases
Acceptability of tongue swabs for tuberculosis screening in migrant settings in northern Italy: A qualitative study
2026 · Renée Codsi, Francesca Saluzzo, et al. · PLOS Global Public Health
PDF
Post-tuberculosis lung disease: a joint effort to provide better management in Europe and Brazil
2026 · Denise Rossato Silva1, Rosella Centis2, et al. · Respiratory Research & Clinical Practice
PDF
Rifamycin-based regimens for preventive treatment in low TB incidence countries
2025 · N. Riccardi, A.C. Repossi, et al. · The International Journal of Tuberculosis and Lung Disease
Which trial do we need? Combination regimen for individuals exposed to multidrug-resistant Mycobacterium tuberculosis
2025 · Divya Shah, Giovanni Fumagalli, et al. · Clinical Microbiology and Infection
Impact of COVID-19 pandemic on Tubercolar Infection treatment in Italy: a multicentric retrospective analysis
2025 · Irene Tomarelli, Giovanni Fumagalli, et al. · European Respiratory Journal
PDF
Risk factors and treatment outcomes of drug-resistant Tuberculosis in migrants
2025 · Giovanni Fumagalli, Niccolò Riccardi, et al. · European Respiratory Journal
PDF
Late Breaking Abstract - Previous pulmonary TB as a risk factor for lung functional impairment: a cross-sectional study in a rural area of Senegal
2025 · Irene Sini, Lucia Allavena, et al. · European Respiratory Journal
Risk factors and treatment outcomes of drug-resistant TB in migrants: a retrospective study
2025 · G. Fumagalli, N. Riccardi, et al. · The International Journal of Tuberculosis and Lung Disease
A destruent case of recurrent primary naso-pharyngeal tuberculosis in a migrant
2025 · Andrea Sergio Sarassi, Niccolò Riccardi, et al. · Infezioni in Medicina
PDF
Mental health and nontuberculous mycobacteria infections: a single center retrospective study in Milan
2024 · Vittoria Moscatt, Giovanni Fumagalli, et al. · European Respiratory Journal
Works count: 27
Citation count: 28
H-index: 3
I10-index:
Year
Topic
Type